Sugi Predict

Sugi Predict / Compounds / SCHEMBL2928546

SCHEMBL2928546

SCHEMBL2928546

CC(C)P(C(C)C)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC22A2 O15244 2/20 0.42
▸ SLC47A1 Q96FL8 2/20 0.42
▸ MAPT P10636 1/20 0.41
▸ GRIN2D O15399 4/20 0.35
▸ GRIN3B O60391 4/20 0.35
▸ GRIN1 Q05586 4/20 0.35
▸ GRIN2A Q12879 4/20 0.35
▸ GRIN2B Q13224 4/20 0.35
▸ GRIN2C Q14957 4/20 0.35
▸ GRIN3A Q8TCU5 4/20 0.35
▸ LMNA P02545 2/20 0.33
▸ SLC22A1 O15245 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ STAT6 P42226 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ EPHX1 P07099 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2919595 0.79 SLC22A2 (0.42) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL1324049 0.75 — —
SCHEMBL7055728 0.74 SLC22A2 (0.42) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL6106967 0.74 SLC22A2 (0.42) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL2929198 0.69 GRIN2D (0.39) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL1092580 0.69 GRIN2D (0.39) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL1877773 0.67 GRIN2D (0.42) SLC22A2SLC47A1GRIN2DGRIN3BGRIN1
SCHEMBL31105670 0.67 SLC22A2 (0.37) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL24541764 0.66 SLC22A2 (0.32) SLC22A2SLC47A1MAPT
SCHEMBL237472 0.65 SLC22A2 (0.56) SLC22A2SLC47A1MAPTGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116965-A1 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2024-04-11 — — US claimed
EP-4267591-A2 ORGANOMETALLIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-11-01 — — EP claimed
CN-116802187-A Organometallic compounds 优米科尔股份公司及两合公司 2023-09-22 — — CN claimed
WO-2022136049-A2 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2022-06-30 — — WO claimed
US-12492281-B2 Polyisocyanurate materials as electrical potting compounds COVESTRO DEUTSCHLAND AG (DE) 2025-12-09 — — US disclosed
CN-113631545-B Polyisocyanurate materials as electrical potting compounds 科思创德国股份有限公司 2025-01-07 — — CN disclosed
US-20240116965-A1 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2024-04-11 — — US disclosed
EP-4267591-A2 ORGANOMETALLIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-11-01 — — EP disclosed
CN-116802187-A Organometallic compounds 优米科尔股份公司及两合公司 2023-09-22 — — CN disclosed
CN-112204065-B Process for preparing polyisocyanate polymers and polyisocyanurate plastics 科思创知识产权两合公司 2023-03-28 — — CN disclosed
CN-109642015-B Method for producing polyisocyanurate plastics by means of phosphine catalysis 科思创德国股份有限公司 2022-09-23 — — CN disclosed
WO-2022136049-A2 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2022-06-30 — — WO disclosed
CN-109642015-A Method for producing polyisocyanurate plastics by means of phosphine catalysis 科思创德国股份有限公司 2019-04-16 — — CN disclosed
WO-2018041800-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO DEUTSCHLAND AG (DE) 2018-03-08 — — WO disclosed
CN-101289427-B Preparation of polyisocyanates containing uretdione groups using phosphine catalysts BAYER MATERIALSCIENCE AG 2012-06-06 — — CN disclosed
US-7709680-B2 Preparation of polyisocyanates containing uretdione groups using phosphine catalysts BAYER MATERIALSCIENCE AG (DE) 2010-05-04 — — US disclosed
EP-1982979-B1 Manufacture of polyisocyanates containing uretdione groups BAYER MATERIALSCIENCE AG (DE) 2010-01-27 — — EP disclosed
US-20080262262-A1 Preparation of polyisocyanates containing uretdione groups using phosphine catalysts BAYER MATERIALSCIENCE AG 2008-10-23 — — US disclosed
EP-1982979-A1 Manufacture of polyisocyanates containing uretdione groups Bayer MaterialScience AG (DE) 2008-10-22 — — EP disclosed
CN-101289427-A Preparation of polyisocyanates containing uretdione groups using phosphine catalysts BAYER MATERIALSCIENCE AG (DE) 2008-10-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262262-A1 Preparation of polyisocyanates containing uretdione groups using phosphine catalysts PPIP5K2, IPMK, INPP5B SLC22A2 3523/4885SLC47A1 4552/4885MAPT 1959/4885
US-20240116965-A1 ORGANOMETALLIC COMPOUNDS DDT, PPOX, PDCD2L SLC22A2 4768/4885SLC47A1 4642/4885MAPT 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.